Tralokinumab: Discovering the Promise of LP 0162 and CAT-354 Tralokinumab, previously known as LP 0162 and CAT-354, represents a promising treatment for chronic dermatitis. This humanized antibody inhibits https://www.targetmol.com/compound/tralokinumab